Squarepoint’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$75.4K Sell
2024
Q2
$190K Buy
2024
Q1
$115K Buy
2022
Q1
Sell
2021
Q4
$27K Sell
2021
Q3
$152K Sell
2021
Q2
$180K Buy
2020
Q1
Sell
2019
Q4
$42K Buy
2019
Q3
$51K Buy
2019
Q2
$42K Buy
2018
Q4
Sell
2018
Q3
$177K Buy
2018
Q2
$105K Buy